| Financial Year |
March 31 2023 |
| Monetary Funds |
1,562,347,793.63 |
| Held-for-trading Financial Assets |
1,455,407,463.18 |
| Notes Receivable |
2,455,004.00 |
| Accounts Receivable |
421,894,640.27 |
| Advances to Suppliers |
25,331,471.48 |
| Other Receivables |
25,945,307.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
854,555.44 |
| Dividend Receivable |
-- |
| Inventories |
14,273,806.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
175,396,178.03 |
| Other Current Assets |
3,492,228.53 |
| Total Current Assets |
3,689,397,757.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
267,416,568.92 |
| Long-term Equity Investment |
218,758,451.48 |
| Investment Properties |
-- |
| Fixed Assetes |
193,147,707.72 |
| Under-construction Projects |
298,923,572.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,597,583.61 |
| R&D expenses |
245,125.84 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,252,076.20 |
| Deferred Income Tax Assets |
28,267,862.25 |
| Other Non-Current Assets |
5,584,549.83 |
| Sub-Total of Non-Current Assets |
1,278,867,803.80 |
| Total Assets |
4,968,265,561.02 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
137,296,302.58 |
| Notes Payable |
-- |
| Accounts Payable |
338,063,899.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,526,408.30 |
| Taxes Payable |
37,732,627.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
19,589,969.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
70,434,670.47 |
| Other Current Liabilities |
8,348,782.53 |
| Sub-Total of Current Liabilities |
1,005,770,006.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
303,954,859.08 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
86,837.29 |
| Other Non-Current Liabilities |
180,000,000.00 |
| Sub-Total of Non-Current Liabilities |
663,250,659.75 |
| Total Liabilities |
1,669,020,666.73 |
| Paid-In Capital(Or Share Stock) |
519,029,360.00 |
| Capital Surplus |
1,499,045,955.97 |
| Surplus Reserve |
239,931,002.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,079,340,948.65 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,299,244,894.29 |
| Owner's Equity（Stockholder's Equity） |
3,299,244,894.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,968,265,561.02 |
